Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Tirzepatide is a dual-agonist peptide researched for its interaction with both GLP-1 receptors and GIP receptors
If met with success, this may provide impetus for further investment and research into utilising other types of peptides, not only to compete with current weight loss drugs available, but for other conditions and diseases that render themselves treatable through peptide agonists
Lipocalin 2 Expression Promotes Tumor Progression and Therapy Resistance by Inhibiting Ferroptosis in Colorectal Cancer
The significance of CHAC2-NRF2 signaling pathway extends beyond development
Patients comparing ipamorelin and sermorelin often start with our peptide therapy service to understand how lab-based treatment plans are evaluated
